Theratechnologies (THTX) Scheduled to Post Quarterly Earnings on Wednesday

Theratechnologies (NASDAQ:THTX) will release its earnings data before the market opens on Wednesday, July 10th.

Theratechnologies (NASDAQ:THTX) last issued its quarterly earnings results on Wednesday, April 10th. The company reported ($0.10) earnings per share (EPS) for the quarter. The company had revenue of $16.25 million during the quarter. On average, analysts expect Theratechnologies to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Theratechnologies Price Performance

Shares of NASDAQ:THTX opened at $1.39 on Tuesday. The company has a market capitalization of $63.91 million, a P/E ratio of -2.28 and a beta of 1.43. Theratechnologies has a 1 year low of $0.88 and a 1 year high of $3.92. The business’s 50 day simple moving average is $1.29 and its 200 day simple moving average is $1.47.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.